These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9706454)

  • 1. Depressive symptoms associated with gonadotropin-releasing hormone agonists.
    Warnock JK; Bundren JC; Morris DW
    Depress Anxiety; 1998; 7(4):171-7. PubMed ID: 9706454
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anxiety and mood disorders associated with gonadotropin-releasing hormone agonist therapy.
    Warnock JK; Bundren JC
    Psychopharmacol Bull; 1997; 33(2):311-6. PubMed ID: 9230649
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.
    Warnock JK; Bundren JC; Morris DW
    Biol Psychiatry; 1998 Mar; 43(6):464-5. PubMed ID: 9532352
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Memory complaints associated with the use of gonadotropin-releasing hormone agonists: a preliminary study.
    Newton C; Slota D; Yuzpe AA; Tummon IS
    Fertil Steril; 1996 Jun; 65(6):1253-5. PubMed ID: 8641510
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Depressive mood symptoms associated with ovarian suppression.
    Warnock JK; Bundren JC; Morris DW
    Fertil Steril; 2000 Nov; 74(5):984-6. PubMed ID: 11056245
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical study on the effectiveness and safety of combined laparoscopy and gonadotropin-releasing hormone agonist in the treatment of endometriosis].
    Song JH; Lu H; Zhang J; Li B
    Zhonghua Fu Chan Ke Za Zhi; 2013 Aug; 48(8):584-8. PubMed ID: 24199923
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prospective randomized study comparing the GnRH-agonist leuprorelin acetate and the gestagen lynestrenol in the treatment of severe endometriosis.
    Regidor PA; Regidor M; Schmidt M; Ruwe B; Lübben G; Förtig P; Kienle E; Schindler AE
    Gynecol Endocrinol; 2001 Jun; 15(3):202-9. PubMed ID: 11447732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy and safety investigation of Kuntai capsule for the add-back therapy of gonadotropin releasing hormone agonist administration to endometriosis patients: a randomized, double-blind, blank- and tibolone-controlled study.
    Chen JM; Gao HY; Ding Y; Yuan X; Wang Q; Li Q; Jiang GH
    Chin Med J (Engl); 2015 Feb; 128(4):427-32. PubMed ID: 25673440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of the gonadotropin-releasing hormone agonist goserelin acetate alone versus goserelin combined with estrogen-progestogen add-back therapy in the treatment of endometriosis.
    Kiilholma P; Tuimala R; Kivinen S; Korhonen M; Hagman E
    Fertil Steril; 1995 Nov; 64(5):903-8. PubMed ID: 7589632
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Anaphylactic reaction to different gonadotropin-releasing hormone agonists for the treatment of endometriosis.
    Lüchinger AB; Mijatovic V; Rustemeyer T; Hompes PG
    Am J Med Sci; 2011 Mar; 341(3):240-2. PubMed ID: 21233692
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of six months of GnRH agonist therapy for endometriosis. Is there an age-related effect on bone mineral density?
    Agarwal SK
    J Reprod Med; 2002 Jul; 47(7):530-4. PubMed ID: 12170527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Prevention and therapy of side effects of gonadotropin-releasing hormone agonist in patients with endometriosis].
    Fang F; Huang M
    Zhonghua Fu Chan Ke Za Zhi; 1999 Aug; 34(8):506-8. PubMed ID: 11360603
    [No Abstract]   [Full Text] [Related]  

  • 13. GnRH agonists: gonadorelin, leuprolide and nafarelin.
    Pace JN; Miller JL; Rose LI
    Am Fam Physician; 1991 Nov; 44(5):1777-82. PubMed ID: 1835275
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Treatment of pelvic endometriosis with goserelin, an LHRH agonist].
    Ventruba P; Crha I; Müller P; Mlyncek M
    Ceska Gynekol; 1996 Feb; 61(1):11-6. PubMed ID: 8624587
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of gonadotropin-releasing hormone agonists, nafarelin, buserelin, and leuprolide, on experimentally induced endometriosis in the rat.
    Mizutani T; Sakata M; Terakawa N
    Int J Fertil Menopausal Stud; 1995; 40(2):106-11. PubMed ID: 7599657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Uterine leiomyomata and sterility: therapy with gonadotropin-releasing hormone agonists and leiomyomectomy.
    Kuhlmann M; Gärtner A; Schindler EM; Regidor PA; Bühler K; Schindler AE
    Gynecol Endocrinol; 1997 Jun; 11(3):169-74. PubMed ID: 9209897
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A comparison of progestogens or oral contraceptives and gonadotropin-releasing hormone agonists for the treatment of endometriosis: a systematic review.
    Jeng CJ; Chuang L; Shen J
    Expert Opin Pharmacother; 2014 Apr; 15(6):767-73. PubMed ID: 24588662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis.
    Vercellini P; Trespidi L; Colombo A; Vendola N; Marchini M; Crosignani PG
    Fertil Steril; 1993 Jul; 60(1):75-9. PubMed ID: 8513962
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Quantification of endometriosis-associated pain and quality of life during the stimulatory phase of gonadotropin-releasing hormone agonist therapy: a double-blind, randomized, placebo-controlled trial.
    Miller JD
    Am J Obstet Gynecol; 2000 Jun; 182(6):1483-8. PubMed ID: 10871469
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Uses of GnRH agonists.
    Garner C
    J Obstet Gynecol Neonatal Nurs; 1994 Sep; 23(7):563-70. PubMed ID: 7996307
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.